Skip to main content
Clinical Trials/NL-OMON19995
NL-OMON19995
Recruiting
Not Applicable

earn to move 0-2 years: early intervention in children with cerebral palsy.

Prof. dr. M. Hadders-AlgraUniversity Medical Centre GroningenDevelopmental Neurology (Postbox CA85)PO Box 30.0019700 RB GroningenThe Netherlands.Tel: +31 50 3614252Email: M.Hadders-Algra@med.umcg.nl0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Prof. dr. M. Hadders-AlgraUniversity Medical Centre GroningenDevelopmental Neurology (Postbox CA85)PO Box 30.0019700 RB GroningenThe Netherlands.Tel: +31 50 3614252Email: M.Hadders-Algra@med.umcg.nl
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Blauw-Hospers CH, De Graaf-Peters VB, Dirks T, Bos AF, Hadders-Algra M. Does early intervention in infants at high risk for a developmental motor disorder improve motor and cognitive development? Neurosci Biobehav Rev 2007a; 31: 1201-12.
- Dirks T, Hadders-Algra M. COPCA – Coping with and Caring for infants with neurological dysfunction – a family centered program. Handleiding, nog niet officiëel uitgeven, 2003.
- Hadders-Algra M. The Neuronal Group Selection Theory: an attractive framework to explain variation in normal motor development. Dev Med Child Neurol 2000a; 42: 566-72.
- Hadders-Algra M. The Neuronal Group Selection Theory: promising principles for understanding and treating developmental motor disorders. Dev Med Child Neurol 2000b; 42: 707-15.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Prof. dr. M. Hadders-AlgraUniversity Medical Centre GroningenDevelopmental Neurology (Postbox CA85)PO Box 30.0019700 RB GroningenThe Netherlands.Tel: +31 50 3614252Email: M.Hadders-Algra@med.umcg.nl

Eligibility Criteria

Inclusion Criteria

  • 1\. Infants (3\-9 months corrected age) at very high risk for CP or with CP and their families.
  • 2\. Participating caregivers must have sufficient comprehension of the Dutch language.

Exclusion Criteria

  • 1\. Children with additional severe congenital disorders, such as serious congenital heart disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials